Vulnerable COPD patients with comorbidities: the role of roflumilast
Melissa Lipari1,2 Pramodini B Kale-Pradhan1,2 1Department of Pharmacy Practice, Wayne State University; 2St John Hospital and Medical Center, Detroit, MI, USA Abstract: Roflumilast is a selective phosphodiesterase-4 (PDE-4) inhibitor that was approved by the US Food and Drug Administration in Februa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2014-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |